还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

8 p& t7 {" d4 m$ N$ }& J( A                               
登录/注册后可看大图

请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

! r5 W- S' [2 h9 B- H7 e可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  


Sub-category:
7 V; {- C' J+ T& c% n4 ~8 n9 KMolecular Targets


, |' g% y% M0 I- MCategory:
) `: d# ~3 o6 A* ?Tumor Biology


6 i; D4 K* W5 o7 p. kMeeting:
2011 ASCO Annual Meeting
$ I3 L1 m& |$ {7 D  A! d: u5 B

Session Type and Session Title:
! f  O, F1 f! E1 DPoster Discussion Session, Tumor Biology
4 C2 t. T/ {4 p* a
$ `% x1 Z% F. Y9 V- e" L% f: |# D
Abstract No:
* l- s8 g* X" g) T( D* x. L$ b10517
+ x) u! q) u' @" \3 R- }
7 j  a3 m4 M+ T
- c* f6 v# j* L- x/ ?/ P0 VCitation:
( ?) e0 p; o/ k2 UJ Clin Oncol 29: 2011 (suppl; abstr 10517)
6 A0 s" n2 j( l( I: y! a+ y- c
+ d; y' E2 K. @/ c* B
Author(s):
% B  \- b/ E$ GJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China


5 t+ h$ I: m' @, ~' L
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

Abstract Disclosures
- ^1 W$ g- D, O: Y( \+ ]- z; q
9 m" {# w: ?' A4 OAbstract:
; R1 X5 a- `: Y- n
" M& ^; v3 j5 E9 \9 Z* {
0 L5 H' @( i# ]. Q( dBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

8 `) ~7 \$ k2 ~# ]8 [3 D9 F6 C没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

' W/ Z, Y. m, w3 D2 f% u化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

! y; \+ d! \8 L/ S  g* O3 L. v                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

" N9 ?9 x! Q2 T: M2 y! i. V/ j平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？

现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊